IGHG3 and onchocerciasis: Considering that IgG3 is more reactive, the OvMCBL02 multiepitope antigen could also be investigated for its role as a vaccine candidate against onchocerciasis since IgG3 immune responses have been reported to be defensive against the parasite [55].